EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C25H22N6O2 |
| Net Charge | 0 |
| Average Mass | 438.491 |
| Monoisotopic Mass | 438.18042 |
| SMILES | CN1CCN(c2nc(C3=C(c4cnc5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1 |
| InChI | InChI=1S/C25H22N6O2/c1-30-10-12-31(13-11-30)25-27-19-9-5-3-7-16(19)22(28-25)21-20(23(32)29-24(21)33)17-14-26-18-8-4-2-6-15(17)18/h2-9,14,26H,10-13H2,1H3,(H,29,32,33) |
| InChIKey | OAVGBZOFDPFGPJ-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | anticoronaviral agent Any antiviral agent which inhibits the activity of coronaviruses. EC 2.7.11.13 (protein kinase C) inhibitor An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of protein kinase C (EC 2.7.11.13). immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antipsoriatic A drug used to treat psoriasis. anti-inflammatory agent Any compound that has anti-inflammatory effects. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| sotrastaurin (CHEBI:90531) has role anti-inflammatory agent (CHEBI:67079) |
| sotrastaurin (CHEBI:90531) has role anticoronaviral agent (CHEBI:149553) |
| sotrastaurin (CHEBI:90531) has role antineoplastic agent (CHEBI:35610) |
| sotrastaurin (CHEBI:90531) has role antipsoriatic (CHEBI:50748) |
| sotrastaurin (CHEBI:90531) has role EC 2.7.11.13 (protein kinase C) inhibitor (CHEBI:37700) |
| sotrastaurin (CHEBI:90531) has role immunosuppressive agent (CHEBI:35705) |
| sotrastaurin (CHEBI:90531) is a N-alkylpiperazine (CHEBI:46845) |
| sotrastaurin (CHEBI:90531) is a N-arylpiperazine (CHEBI:46848) |
| sotrastaurin (CHEBI:90531) is a indoles (CHEBI:24828) |
| sotrastaurin (CHEBI:90531) is a maleimides (CHEBI:55417) |
| sotrastaurin (CHEBI:90531) is a organic molecular entity (CHEBI:50860) |
| sotrastaurin (CHEBI:90531) is a quinazolines (CHEBI:38530) |
| IUPAC Name |
|---|
| 3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]-1H-pyrrole-2,5-dione |
| INNs | Source |
|---|---|
| sotrastaurin | WHO MedNet |
| sotrastaurina | WHO MedNet |
| sotrastaurine | WHO MedNet |
| sotrastaurinum | WHO MedNet |
| Synonyms | Source |
|---|---|
| AEB 071 | ChEBI |
| AEB-071 | ChEBI |
| AEB071 | ChemIDplus |
| NVP-AEB071 | ChEMBL |
| Registry Numbers | Sources |
|---|---|
| Reaxys:13012870 | Reaxys |
| CAS:425637-18-9 | ChemIDplus |
| Citations |
|---|